Health Care • Biotechnology: Pharmaceutical Preparations
$78.80 ▲ +1.00
(+1.29%)
MKT CAP: $32.56B • VOL: 2.94M
52W L $69 52W H $145
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$66
MEDIAN
$88
MEAN
$90
HIGH
$107
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE ZTS TAPE
ZTS // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $95.35 | $90.62 | 2025-02-14 | $71.71 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $99.29 | $92.98 | 2025-02-06 | $74.07 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $89.83 | $86.68 | 2025-01-29 | $75.65 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $80.38 | — | 2025-01-17 | $77.22 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $69.34 | $74.86 | 2025-01-09 | $70.13 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $93.77 | $81.95 | 2024-12-18 | $68.56 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $76.44 | $79.59 | 2024-12-04 | $73.28 | -4.3% | 48% | C |